<DOC>
	<DOCNO>NCT02553681</DOCNO>
	<brief_summary>This six month , subject-masked , contralateral , parallel-group , randomised , daily wear study . All subject wear Test lens one eye Control lens eye . Data first four week Test Control lens exposure use FDA 510 ( k ) submission .</brief_summary>
	<brief_title>Clinical Evaluation HPT Treated Rigid Contact Lenses Made From Roflufocon D</brief_title>
	<detailed_description />
	<mesh_term>Refractive Errors</mesh_term>
	<criteria>Willing able sign inform consent form Aged ≥18 year old Experienced wearer rigid gas permeable contact lenses Subject 's habitual contact lens must make Contamac 's Optimum Extra ( roflufocon D ) material Subjects must own spectacle contact lenses prior enrolment trial Spherical power 10.00 D +10.00 D ( vertex distance 0 mm ) Corneal astigmatism ≤2.00 D • Eye injury surgery within 3 month immediately prior enrolment trial Preexisting ocular irritation would preclude contact lens fit Currently enrol ophthalmic clinical trial Evidence systemic ocular abnormality , infection disease likely affect successful wear contact lenses use accessory solution , determine investigator Any use medication contact lens wear could contradict , determine investigator Current extendedwear user ( sleepin overnight ) Current monovision lens wearer Current wearer multifocal contact lenses Current wearer toric contact lens ( front surface design ) Current wearer astigmatic contact lens ( posterior surface design ) Has report `` Strong '' comfort vision preference eye habitual RGP lenses Unacceptable fit habitual lens Pregnant woman nurse mother Bestcorrected visual acuity bad 6/9 ( LogMAR : +0.20 ; Snellen decimal : 0.63 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>